Loading products…
Loading products…


This precision-compounded peptide therapy combines CJC-1295, Ipamorelin and AOD-9604. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release natural growth hormone. It supports anti-aging, increased lean body mass, fat loss, deeper sleep, and improved recovery without disrupting normal hormonal rhythms. Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary to release growth hormone without raising cortisol or prolactin. It promotes fat loss, muscle preservation, faster recovery, and improved sleep when combined with GHRH peptides. AOD-9604 is a modified fragment of human growth hormone designed to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage) without affecting blood sugar or tissue growth. It is a targeted tool for supporting fat loss and body composition improvement. Together, these peptides work synergistically to support the targeted therapeutic goals of this formulation. Physician consultation and oversight are required.